Spanish Red Biotech Pipeline

MSD

Pembrolizumab

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Pembrolizumab in Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Phase: 2Phase II in Spain, 1Phase I